Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Organ transplant Stories

2012-05-31 06:28:23

HORSHOLM, Denmark, May 31, 2012 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that a subgroup analysis of African-American stable kidney transplant patients enrolled in Study 3001, a Phase 3 non-inferiority study, suggests that these patients may be safely converted from twice-daily Prograf(®) to once-daily LCP-Tacro. In addition, there was a trend toward fewer biopsy-proven acute rejections (BPARs) with LCP-Tacro compared to Prograf. The analysis will be...

2012-05-30 10:25:35

WINSTON-SALEM, N.C., May 30, 2012 /PRNewswire/ -- Tengion, Inc. (NASDAQ: TNGN), a leader in regenerative medicine, today announced that its Board of Directors has approved a reverse split of its common stock at a ratio of 1-for-10. The Company's common stock will begin trading on a split-adjusted basis when the NASDAQ Capital Market opens on June 14, 2012. The reverse stock split, which was approved by Tengion stockholders, is intended to enable Tengion to regain compliance with the NASDAQ...

2012-05-25 06:24:17

LOS ANGELES, May 25, 2012 /PRNewswire-USNewswire/ --The UCLA Health System has launched the UCLA Face Transplantation Program, the first surgical program of its kind in the western United States and one of only a handful in the nation. "Facial transplantation offers the potential to restore humanity to persons who have suffered the devastating loss of their face," said Dr. Kodi Azari, chief of reconstructive transplantation and associate professor of surgery at the David Geffen School of...

2012-05-25 06:24:09

CHENGDU, China, May 25, 2012 /PRNewswire-Asia/ -- Recently, Wang Qiao, the eight-year program student of Liver and Vascular Surgery of West China Hospital tutored under Yan Lynan, went to San Francisco to attend the 18th ILTS (International Liver Transplantation Society) annual meeting with the director of his department, Mr. Li Bo. (Photo: http://photos.prnewswire.com/prnh/20120525/CN13960) The theme of the meeting is "The Pros and Cons Trade-Off for Liver Transplantation", and...

2012-05-24 02:27:49

TUCSON, Ariz., May 24, 2012 /PRNewswire/ -- SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that the SynCardia temporary Total Artificial Heart has recently replaced left ventricular assist devices (LVADs) in seven patients suffering from end-stage heart failure. (Photo: http://photos.prnewswire.com/prnh/20120524/LA13121) An LVAD is a continuous-flow, mechanical pump...

2012-05-23 20:05:27

Loyola University Medical Center researchers are reporting one of the first studies to examine how patients and families are soliciting living kidney donors on Facebook. Researchers examined 91 Facebook pages that were seeking kidney donations for patients ranging in age from 2 to 69. Twelve percent of the pages reported receiving a kidney transplant and 30 percent reported that potential donors had stepped forward to be tested to determine whether they were compatible. One page...

2012-05-23 14:21:34

FRAMINGHAM, Mass. and SYDNEY, May 23, 2012 /PRNewswire/ -- HeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced the publication of results from ADVANCE, the Company's U.S. clinical trial evaluating the use of the HeartWare® Ventricular Assist System as a bridge to heart transplantation in patients with advanced heart...

2012-05-23 06:24:19

- CanadaAM.ctv.ca hosts live-chat with living donors, donor families, recipients, and organ donation professionals taking questions throughout the broadcast - To tweet this release: http://bit.ly/KavCMi TORONTO, May 23, 2012 /CNW/ -  Canadian organ donor advocate and recent transplant recipient Hélène Campbell catapulted organ donation awareness into the international spotlight with endorsements by pop superstar and fellow Canadian Justin Bieber and...

2012-05-23 02:26:04

HORSHOLM, Denmark, May 23, 2012 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that it contemplates restructuring the company's operations in order to fully focus its resources on the completion of the development and subsequent commercialization of LCP-Tacro(TM), Veloxis' product candidate for the prevention of organ rejection. It is planned that a discontinuation of other pipeline activities will take place, including early phase research activities. The basis for...

Italian Baby Receives World's Smallest Artificial Heart
2012-05-23 04:25:44

Connie K. Ho for RedOrbit.com Italian doctors recently announced they completed an operation that implanted the smallest artificial heart in a 16-month-old baby boy. He received the device prior to obtaining a permanent organ donation. The operation was completed at Bambino Gesù Hospital, a children´s hospital located in the capital city of Italy. The hospital, first founded in 1869, is now part of the Italian National Healthcare System. The organization focuses on...


Latest Organ transplant Reference Libraries

0_886104d1c1c698f3a531e056704457d5
2010-10-14 16:46:25

The artificial heart, a mechanical heart replacement, is typically used in order to bridge the time to heart transplant or to replace the heart in case a transplant is impossible. Often ventricular assist devices are confused with mechanical hearts because the assist the heart through pumps. They are also different from a cardiopulmonary bypass machine which is an external device used to provide the function of the heart and lungs. CPBs are usually only used for a few hours at a time,...

More Articles (1 articles) »